GLT8D2 and ovarian carcinoma: Moreover, overexpression of GLT8D2 was associated with chemoresistance in human ovarian cancer, which show that 72.7% of GLT8D2-overexpression ovarian cancer samples cases exhibited chemoresistance (Fig. 1b), suggesting that GLT8D2-overexpression might be involved in ovarian cancer chemotherapy failure.